Current review of TP53 pathogenic germline variants in breast cancer patients outside Li‐Fraumeni syndrome

C Fortuno, PA James, AB Spurdle - Human mutation, 2018 - Wiley Online Library
Pathogenic germline variants in TP53 predispose carriers to the multi‐cancer Li‐Fraumeni
syndrome (LFS). Widespread multigene panel testing is identifying TP53 pathogenic …

[HTML][HTML] Current state of knowledge of human DNA polymerase eta protein structure and disease-causing mutations

BC Feltes, CFM Menck - Mutation Research/Reviews in Mutation Research, 2022 - Elsevier
POLη, encoded by the POLH gene, is a crucial protein for replicating damaged DNA and the
most studied specialized translesion synthesis polymerases. Mutations in POLη are …

[HTML][HTML] Breast cancer epidemiology among Lebanese women: an 11-year analysis

MY Fares, HA Salhab, HH Khachfe, HM Khachfe - Medicina, 2019 - mdpi.com
Background and Objectives: Breast cancer is the most prevalent cancer in women
worldwide. Lebanon is a developing country in the Middle East with a prominent breast …

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

E Girard, S Eon‐Marchais, R Olaso… - … journal of cancer, 2019 - Wiley Online Library
Pathogenic variants in BRCA1 and BRCA2 only explain the underlying genetic cause of
about 10% of hereditary breast and ovarian cancer families. Because of cost‐effectiveness …

[HTML][HTML] Frequency of pathogenic germline mutations in early and late onset familial breast cancer patients using multi-gene panel sequencing: an Egyptian study

A Nassar, ARN Zekri, MM Kamel, MH Elberry, MM Lotfy… - Genes, 2022 - mdpi.com
Background: Precision oncology has been increasingly used in clinical practice and rapidly
evolving in the oncology field. Thus, this study was performed to assess the frequency of …

[HTML][HTML] Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations

M Suszynska, P Kozlowski - Genes, 2020 - mdpi.com
Over the last two decades, numerous BARD1 mutations/pathogenic variants (PVs) have
been found in patients with breast cancer (BC) and ovarian cancer (OC). However, their role …

Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma

JL Maciaszek, N Oak, W Chen… - Molecular …, 2019 - molecularcasestudies.cshlp.org
Patients harboring germline pathogenic biallelic variants in genes involved in the
recognition and repair of DNA damage are known to have a substantially increased cancer …

The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data

P Gianni, E Matenoglou, G Geropoulos, N Agrawal… - Clinical Breast …, 2022 - Elsevier
The development of breast cancer depends on several risk factors, including environmental,
lifestyle and genetic factors. Despite the evolution of DNA sequencing techniques and …

Genome‐wide association analysis identifies a GLUL haplotype for familial hepatitis B virus‐related hepatocellular carcinoma

YY Lin, MW Yu, SM Lin, SD Lee, CL Chen, DS Chen… - Cancer, 2017 - Wiley Online Library
BACKGROUND A family history of liver cancer increases the risk of developing
hepatocellular carcinoma (HCC) by 2‐fold to 10‐fold among patients with chronic hepatitis B …

Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region

SC Elalaoui, FZ Laarabi, L Afif, J Lyahyai… - Breast Cancer Research …, 2022 - Springer
Purpose Breast cancer (BC) is the most common form of female cancer around the world.
BC is mostly sporadic, and rarely hereditary. These hereditary forms are mostly BRCA1-and …